Timedora
Free Practice Quiz Question List

7 Reversal Agents and Bleeding Management Online Quiz Questions

Use this free practice quiz with 20 questions to review 7 Reversal Agents and Bleeding Management, test your knowledge, and prepare for your next test or exam.

20 questions
01
True or false
1 point

True or false: A normal routine clotting test is sufficient to rule out clinically important direct oral anticoagulant activity.

  1. A

    True

  2. B

    False

02
Fill in the blank
1 point

Protamine reverses enoxaparin only .

03
Fill in the blank
1 point

For life-threatening warfarin-associated bleeding, may be used if four-factor prothrombin complex concentrate is unavailable.

04
Written response
1 point

A patient taking dabigatran develops major bleeding. What specific reversal agent should be given?

05
Written response
1 point

On what date did U.S. commercial sales of andexanet alfa end? Enter the full date.

06
True or false
1 point

True or false: For a patient taking aspirin who has spontaneous intracranial hemorrhage and is not undergoing emergency surgery, platelet transfusion should not be given routinely.

  1. A

    True

  2. B

    False

07
Choose one
1 point

As of November 5, 2026, a patient taking apixaban has uncontrolled, life-threatening bleeding in the United States. Which statement best describes a commonly used reversal approach and an important limitation?

  1. A

    Use andexanet alfa as a U.S. product that is still being sold.

  2. B

    Consider 4F-PCC under institutional protocols; it is nonspecific and does not bind or remove apixaban.

  3. C

    Use idarucizumab, which specifically binds apixaban.

  4. D

    Use protamine to neutralize apixaban.

08
Choose one
1 point

A patient taking warfarin has an intracranial hemorrhage and an INR of 4.2. Which reversal strategy is preferred?

  1. A

    Stop warfarin and give four-factor prothrombin complex concentrate plus intravenous vitamin K.

  2. B

    Give intravenous vitamin K alone because it immediately replaces clotting factors.

  3. C

    Give protamine because it reverses all anticoagulants.

  4. D

    Give platelets alone to reverse warfarin.

09
Choose one
1 point

A patient has serious bleeding during an unfractionated heparin infusion. Which approach to protamine administration is appropriate?

  1. A

    Give a fixed protamine dose rapidly, regardless of the recent heparin amount.

  2. B

    Use vitamin K and infuse it rapidly to avoid a reaction.

  3. C

    Calculate protamine from the amount of heparin given recently and administer it slowly.

  4. D

    Use idarucizumab because it neutralizes unfractionated heparin.

10
Choose all
1 point

For suspected major or life-threatening antithrombotic-associated bleeding, which immediate actions are appropriate? Select all that apply.

  1. A

    Stabilize airway, breathing, and circulation.

  2. B

    Wait for every laboratory result before beginning time-critical care.

  3. C

    Control the bleeding source.

  4. D

    Assume reversal agents and PCC have no important risks.

  5. E

    Obtain appropriate blood tests and type and screen or crossmatch as needed.

11
Choose all
1 point

When estimating whether clinically important apixaban effect may remain, which factors should clinicians consider? Select all that apply.

  1. A

    When the last apixaban dose was taken.

  2. B

    The patient's kidney function.

  3. C

    A routine clotting test alone as a definitive measure of apixaban effect.

  4. D

    A drug-specific anti-Xa level, if available.

12
Open ended
1 point

A patient with impaired renal function who takes dabigatran develops a major bleed. Describe the specific reversal treatment and how clinicians should assess and respond to possible recurrent anticoagulant effect afterward.

13
True or false
1 point

True or false: For a patient taking aspirin who has intracranial hemorrhage and requires emergency neurosurgery, platelet transfusion may be considered.

  1. A

    True

  2. B

    False

14
Choose one
1 point

In spontaneous intracranial hemorrhage associated with aspirin use, is the effectiveness of desmopressin, with or without platelet transfusion, for limiting hematoma expansion established?

  1. A

    True, desmopressin is established as effective in every such case.

  2. B

    False, its effectiveness for limiting hematoma expansion is uncertain.

  3. C

    True, desmopressin is established as harmful in every such case.

15
Choose one
1 point

Why should protamine be administered slowly when reversing unfractionated heparin?

  1. A

    Rapid infusion can cause severe hypotension or anaphylactoid reactions.

  2. B

    Rapid infusion prevents protamine from reversing unfractionated heparin.

  3. C

    Slow infusion makes protamine unable to neutralize heparin.

  4. D

    Rapid infusion is required to prevent recurrent anticoagulant effect.

16
Written response
1 point

A patient taking dabigatran develops major bleeding. What total dose of idarucizumab is given intravenously? Enter the dose in grams.

17
Choose one
1 point

A patient with serious bleeding continues to bleed after receiving protamine for enoxaparin. What further management approach is supported?

  1. A

    Assume bleeding is controlled because protamine fully neutralizes enoxaparin.

  2. B

    Repeat protamine until all anti-factor Xa activity is eliminated.

  3. C

    Provide supportive care and pursue measures to control the bleeding source.

  4. D

    Wait for anti-factor Xa activity to disappear before taking any further action.

18
Written response
1 point

A patient taking apixaban has life-threatening bleeding. If available, what drug-specific test may help assess clinically significant apixaban activity? Do not delay emergency treatment while awaiting the result.

19
Choose one
1 point

For life-threatening warfarin-associated bleeding treated with 4F-PCC, what is the role of intravenous vitamin K?

  1. A

    Vitamin K rapidly replaces the clotting factors, so 4F-PCC is unnecessary.

  2. B

    Intravenous vitamin K supports sustained production of vitamin K–dependent clotting factors after the PCC effect wanes.

  3. C

    Vitamin K binds warfarin directly and removes it from the body.

  4. D

    Vitamin K prevents thrombosis caused by 4F-PCC.

20
Choose one
1 point

A patient with impaired renal function and dabigatran-associated major bleeding receives idarucizumab. What follow-up is important because renal impairment may prolong dabigatran exposure?

  1. A

    Assume the reversal is permanent and no further assessment is needed.

  2. B

    Repeat idarucizumab automatically at a fixed interval in every patient.

  3. C

    Use a normal routine clotting test to rule out any recurrent drug effect.

  4. D

    Reassess the patient and relevant coagulation tests for recurrent anticoagulant effect.